According to Yun Medical Devices, there are currently 354 manufacturers of orthopedic implant devices in the middle reaches of the country, mainly located in economically developed provinces and cities such as Beijing, Jiangsu, Shanghai, and Guangdong, and the industry has formed a certain concentration.

Distribution of Orthopedic Implant Device Companies in my country: (Unit: Family)

Among the above-mentioned 354 companies, there are 248 companies involved in traumatic implant devices such as bone plates and orthopedic nails. The competition is relatively sufficient, and it is the subdivision of orthopedic implant devices with the highest localization rate. Due to the low technical threshold of trauma products, artificial joints and spine products, there are more companies participating in the industry. With the promotion of national and local orthopedic consumables collection policies, companies with low technical levels and poor competitiveness in the industry will be eliminated and integrated , The industry concentration is expected to increase in the future.

a, trauma

The market pattern of traumatic implant devices in my country in 2019:

b, spine

The degree of localization of spinal implants is lower than that of trauma. In 2019, the localization rate was 40.2%. The main market share was occupied by foreign products. Foreign companies Johnson & Johnson and Medtronic accounted for more than half of the market. The domestic company Weigao Orthopedics is the domestic spine The leader in implantable devices, ranking third, with a market share of 7.9%.

The market pattern of spinal implant devices in my country in 2019

c, joint

As of the end of January 2021, my country has 97 domestic manufacturers of joint implant devices, mainly located in Beijing (32) and Shanghai (20). The degree of localization of joint products is low, with a localization rate of 27.5% in 2019. According to relevant reports on punctuation information, the top five companies in the joint implantable medical device market in my country in 2019 are Zimmer, Johnson & Johnson, Akcome Medical, Chunli Medical and Link Orthopedics. Among them, domestic companies Akcome Medical and Chunli Medical have It has achieved a breakthrough in the competition and is currently the leading domestic enterprise in joint implant products.

d, sports medicine

The Chinese sports medicine market is the second largest market in the world, second only to the United States in scale. As of last year, China's sports medicine implant consumables market has reached more than 5 billion yuan in output value and is still growing rapidly, while the scale of the sports rehabilitation market will reach tens of billions of yuan.

According to the classification of usage, sports medicine equipment can be divided into the following four categories:

my country's sports medicine market is currently dominated by overseas giants. The main giants include Arthrex, Xerox, Stryker, Johnson & Johnson, Kangmei, etc., and their market share in 2018 was 31%, 26%, 15%, 12% and 8% ( A total of 86%), the product layout is comprehensive. Domestic companies are currently actively deploying in the field of sports medicine. Among the listed companies, Weigao Orthopedics, Kailitai, Dabo Medical, Chunli Medical, etc. are all actively joining, and currently the forefront is Kailitai, which was launched in 2018. Medical orthopedic suture S-Weave is the first professionally designed suture for sports medicine in China. In addition, Kailitai has invested in a number of sports medicine companies in the past two years to enrich its product layout, including a 60 million yuan strategy Invest in Shanghai Ligetai Biotech, equity investment in Shanghai Yidong Medical, equity participation in Dongzhi Medical, etc.

Non-listed companies such as Demei Medical, Hangzhou Ruijian, and Tianxing Bomadi have more complete products. On the whole, domestic companies are in an early stage of development, but they have the ability to compete with foreign capital. The substitution of domestic imports is expected to accelerate.